InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
50%
T+90 mean return
-28.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Shulman Joseph, Chief Technical Officer. Officer active across 1 company, notably Rhythm Pharmaceuticals, INC.. In total, 23 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €1.4m. History available since 9 February 2023. The latest transaction was filed on 28 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations23 total
2,094 shares@ US$27.3550.0% of flowCommon StockSEC:0001104659-25-104437
2,094 shares@ US$27.350.0008% mcap50.0% of flowCommon StockSEC:0001104659-25-104437:0
4,125 sharesCommon StockSEC:0001104659-25-015324:0
462 shares@ US$56.390.7% of flowCommon StockSEC:0001104659-25-014259:0
2,656 sharesCommon StockSEC:0001104659-25-011679:0
3,938 sharesCommon StockSEC:0001104659-25-009286:0
7,969 shares@ US$6.801.5% of flowCommon StockSEC:0001104659-24-117941:0
65,175 shares@ US$21.3837.7% of flowCommon StockSEC:0001104659-24-117940:0
10,468 shares@ US$27.357.7% of flowCommon StockSEC:0001104659-24-080910:0
5,313 shares@ US$21.383.0% of flowCommon StockSEC:0001104659-24-080214:0
3,984 shares@ US$6.800.7% of flowCommon StockSEC:0001104659-24-060559:0
18,235 shares@ US$40.3419.6% of flowCommon StockSEC:0001104659-24-037927:0
15,515 shares@ US$39.2216.3% of flowCommon StockSEC:0001104659-24-036317:0
33,750 shares0Common StockSEC:0001104659-24-026155:0
1,865 shares@ US$50.002.5% of flowCommon StockSEC:0001104659-24-024605:0
2,656 sharesCommon StockSEC:0001104659-24-022537:0
3,938 sharesCommon StockSEC:0001104659-24-010798:0
2,400 shares@ US$21.381.4% of flowCommon StockSEC:0001104659-23-130499:0
27,890 shares@ US$6.805.2% of flowCommon StockSEC:0001104659-23-119097:0
1,563 sharesCommon StockSEC:0001104659-23-022114:0
931 shares@ US$27.510.7% of flowCommon StockSEC:0001104659-23-022067:0
2,657 sharesCommon StockSEC:0001104659-23-019810:0
1,563 sharesCommon StockSEC:0001104659-22-023952:0
23 of 23 declarations
About Shulman Joseph
Shulman Joseph is the Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC. He is responsible for the technical strategy and product development of the company. His role is essential in ensuring that RHYTHM's innovations meet market needs and safety standards.
